Purchases and Sales Made in Q3 2024 in Xeris Biopharma Holdings, Inc. (XERS)
This table provides information about the institutional ownership of Xeris Biopharma Holdings, Inc. (XERS) during Q3 2024. The information is specifically focused on institutions that hold shares of Xeris Biopharma Holdings, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-251K- 14.78% |
$517K - $742K
|
1.45M
$5.42M
|
|
Nov 14, 2024
Q3 2024
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-258K- 40.54% |
$531K - $763K
|
378K
$1.42M
|
|
Nov 05, 2024
Q3 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-578K- 95.48% |
$1.19M - $1.71M
|
27.4K
$103K
|